SPONDYLOARTHRITIS RESEARCH AND TREATMENT NETWORK (EIN 464072112) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2013

Legal Domicile

Principal Officer

MATTHEW STOLL PHD MD

Phone

3606002170

Tax Period

2023-08-01 to 2024-07-31

SPONDYLOARTHRITIS RESEARCH AND TREATMENT NETWORK, founded in 2013, is a small nonprofit in the Diseases & Disorders sector that reported $669K in total revenue in fiscal year 2023. Revenue fell 38% from the prior year — a significant decline worth monitoring. Expenses of $598K left a modest 11% surplus.

Mission

OUR MISSION IS TO FOSTER SPONDYLOARTHRITIS RESEARCH AND EDUCATION IN NORTH AMERICA. WE ACCOMPLISH THIS MISSION BY ENGAGING IN RESEARCH PROJECTS, SUPPORTING YOUNG RESEARCHERS, AND CONDUCTING AN ANNUAL MEETING HIGHLIGHTING IMPORTANT EDUCATION AND RESEARCH PROGRAMS. OUR VISION IS A WORLD FREE OF SPONDYLOARTHRITIS THROUGH LEADERSHIP IN RESEARCH AND EDUCATION.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $630,000

Program Service Revenue $2,750

Investment Income $36,362

Other Revenue $0

TOTAL REVENUE $669,112

Expense Breakdown

Grants Paid $189,000

Salaries & Benefits $98,400

Fundraising Expenses $0

Program Expenses $493,595

Other Expenses $310,608

TOTAL EXPENSES $598,008

Year-over-Year Comparison

	2023	2022	Change
Revenue	$669,112	$1,072,855	-0.4%
Expenses	$598,008	$820,283	-0.3%
Net Income	$71,104	$252,572	-0.7%

Key Indicators

✓ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$106,300

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MATTHEW STOLL PHD MD	CHAIR	10.00	Officer Director	$0	$0	$0
JOERG ERMANN MD	IMMEDIATE PAST CHAIR	3.00	Officer Director	$0	$0	$0
IGNACIO GARCIA-VALLARDES MD	DIRECTOR	2.00	Officer Director	$0	$0	$0
SIBA RAYCHAUDHURI MD	DIRECTOR	2.00	Director	$0	$0	$0
MAUREEN DUBREUIL MD	TREASURER	2.00	Officer Director	$0	$0	$0
NIGIL HAROON PHD MD	VICE-CHAIR	3.00	Officer Director	$0	$0	$0
JEAN LIEW MD MSC	DIRECTOR	3.00	Director	$0	$0	$0
MARINA MAGREY MD	SECRETARY	2.00	Officer Director	$0	$0	$0
JOHN REVEILLE MD	DIRECTOR	2.00	Director	$0	$0	$0
MOHAMAD BITTAR MD	DIRECTOR	3.00	Director	$0	$0	$0
AKIHIRO NAKAMURA MD PHD	DIRECTOR	2.00	Director	$0	$0	$0
LISA SPIEGEL	EXECUTIVE DIRECTOR	30.00	Officer	$106,300	$0	$106,300

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$669,112	$598,008	$2,444,182	$71,104
2023	$1,072,855	$820,283	$3,043,861	$252,572
2022	$1,197,948	$2,108,521	$2,490,686	$-910,573
2021	$903,973	$1,434,698	$3,243,342	$-530,725
2020	$1,051,122	$451,083	$3,730,850	$600,039
2019	$1,754,199	$337,618	$3,170,811	$1,416,581
2019	$2,005,831	$451,796	$2,974,584	$1,554,035

SPONDYLOARTHRITIS RESEARCH AND TREATMENT NETWORK